ORAL PRESENTATION
Title : Dual Activity of PAC: Neurotrophicity and
Neuroprotection against amyloid peptides causing Alzheimer’s disease
Author : Fadia El
Bitar
King Faisal
Specialist Hospital and Research Centre, Saudi Arabia
Abstract : Alzheimer’s
disease (AD) is the most common cause of dementia
in the elderly. The toxicity of -amyloid (A)
peptides is thought to be involved in neuronal damage in this
pathology. Multiple studies
focused on role of neuroprotective molecules to attenuate the toxic
consequences of A peptides in the development of AD.
In the present work, our objective is to
investigate in vitro if PAC which is the synthetic analogue of curcumin displays
#neuroprotective activity against A peptide-induced #neurotoxicity, using rat neuroblastoma B104 as cell culture model.
Our results showed that PAC is not neurotoxic per se. In addition, PAC
showed a striking #neurotrophic activity in cells cultured at low
density. This neuronal outgrowth increases importantly with increasing days of
culture starting from 2 folds increase at day 2 to 3 folds increase at day 5.
The number of neurites per cell rises also in presence of PAC.
Most importantly, we demonstrate the
capacity of PAC to correct sA25-35 neurotoxicity. The percentage of cell viability
increases significantly by PAC at 0.5µM in presence of sA 25-35 compared to that
in presence of the peptide alone .Interestingly, our neurotrophic and neuroprotection
studies showed the PAC was 20 times more efficient than curcumin. Both PAC and
curcumin displayed an effect on cell-cell interaction.
Thus, our
results revealed neuroprotective properties of PAC against A peptide. The
continuity in examining the mechanism(s) underlying PAC activity is promising
towards identifying efficient therapy for AD.
No comments:
Post a Comment